{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:36:49Z","timestamp":1790692609419,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T00:00:00Z","timestamp":1655942400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.anai.2022.06.014","type":"journal-article","created":{"date-parts":[[2022,6,19]],"date-time":"2022-06-19T09:35:54Z","timestamp":1655631354000},"page":"497-506.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Lymphocyte transformation test for drug allergy detection"],"prefix":"10.1016","volume":"129","author":[{"given":"Andreas","family":"Gl\u00e4ssner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Dubrall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonie","family":"Weinhold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhardt","family":"Sachs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.anai.2022.06.014_bib0001","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/all.12350","article-title":"International consensus on drug allergy","volume":"69","author":"Demoly","year":"2014","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.anai.2022.06.014_bib0002","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s40629-015-0052-6","volume":"24","author":"Brockow","year":"2015","journal-title":"Allergo J Int"},{"key":"10.1016\/j.anai.2022.06.014_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2021.113036","article-title":"Lymphocyte transformation test: history and current approaches","volume":"493","author":"Sachs","year":"2021","journal-title":"J Immunol Methods"},{"issue":"8","key":"10.1016\/j.anai.2022.06.014_bib0004","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/j.1398-9995.2004.00547.x","article-title":"The lymphocyte transformation test in the diagnosis of drug hypersensitivity","volume":"59","author":"Pichler","year":"2004","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.anai.2022.06.014_bib0005","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.3390\/ijms18061222","article-title":"The value of in vitro tests to diminish drug challenges","volume":"18","author":"Mayorga","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.anai.2022.06.014_bib0006","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jaci.2018.09.022","article-title":"Controversies in drug allergy: in vitro testing","volume":"143","author":"Mayorga","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2022.06.014_bib0007","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.00469","article-title":"Lymphocyte transformation test (LTT) in allergy to benznidazole: a promising approach [e-pub ahead of print]","volume":"10","author":"Marques-Mej\u00edas","year":"2019","journal-title":"Front Pharmacol"},{"issue":"4","key":"10.1016\/j.anai.2022.06.014_bib0008","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/all.14062","article-title":"Assessment of drug causality in Stevens-Johnson syndrome\/toxic epidermal necrolysis: concordance between lymphocyte transformation test and ALDEN","volume":"75","author":"Bell\u00f3n","year":"2020","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.anai.2022.06.014_bib0009","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/cea.13076","article-title":"Sensitivity and specificity of the lymphocyte transformation test in drug reaction with eosinophilia and systemic symptoms causality assessment","volume":"48","author":"Caba\u00f1as","year":"2018","journal-title":"Clin Exp Allergy"},{"issue":"8","key":"10.1016\/j.anai.2022.06.014_bib0010","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/all.12886","article-title":"In vitro tests for drug hypersensitivity reactions: an ENDA\/EAACI drug allergy interest group position paper","volume":"71","author":"Mayorga","year":"2016","journal-title":"Allergy"},{"issue":"8","key":"10.1016\/j.anai.2022.06.014_bib0011","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.3390\/ijms18081737","article-title":"In vitro assays in severe cutaneous adverse drug reactions: are they still research tools or diagnostic tests already?","volume":"18","author":"Porebski","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.anai.2022.06.014_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2021.113062","article-title":"ELISPOT assay as a diagnostic tool in drug hypersensitivity reactions","volume":"495","author":"Porebski","year":"2021","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.anai.2022.06.014_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2021.113098","article-title":"Lymphocyte transformation test and cytokine detection assays: determination of read out parameters for delayed-type drug hypersensitivity reactions","volume":"496","author":"Srinoulprasert","year":"2021","journal-title":"J Immunol Methods"},{"issue":"11","key":"10.1016\/j.anai.2022.06.014_bib0014","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.anai.2022.06.014_bib0015","series-title":"Doing Meta-analysis With R: A Hands-On Guide","author":"Harrer","year":"2021"},{"issue":"2","key":"10.1016\/j.anai.2022.06.014_bib0016","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis","volume":"56","author":"Duval","year":"2000","journal-title":"Biometrics"},{"issue":"12","key":"10.1016\/j.anai.2022.06.014_bib0017","first-page":"865","article-title":"Multiple drug allergy in patients with cutaneous adverse drug reactions diagnosed by in vitro drug-induced interferon-gamma release","volume":"10","author":"Halevy","year":"2008","journal-title":"Isr Med Assoc J"},{"issue":"9","key":"10.1016\/j.anai.2022.06.014_bib0018","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/cea.12145","article-title":"In vitro drug causality assessment in Stevens-Johnson syndrome - alternatives for lymphocyte transformation test","volume":"43","author":"Porebski","year":"2013","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"10.1016\/j.anai.2022.06.014_bib0019","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1398-9995.2009.02143.x","article-title":"In vitro detection and characterization of drug hypersensitivity using flow cytometry","volume":"65","author":"Martin","year":"2010","journal-title":"Allergy"},{"issue":"9","key":"10.1016\/j.anai.2022.06.014_bib0020","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/j.1398-9995.2009.01985.x","article-title":"Drug-specific in vitro release of IL-2, IL-5, IL-13 and IFN-gamma in patients with delayed-type drug hypersensitivity","volume":"64","author":"Lochmatter","year":"2009","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.anai.2022.06.014_bib0021","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1046\/j.1365-2222.2002.01382.x","article-title":"Determination of interleukin-5 secretion from drug-specific activated ex vivo peripheral blood mononuclear cells as a test system for the in vitro detection of drug sensitization","volume":"32","author":"Sachs","year":"2002","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"10.1016\/j.anai.2022.06.014_bib0022","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2340\/00015555-1386","article-title":"The potential of using enzyme-linked immunospot to diagnose cephalosporin-induced maculopapular exanthems","volume":"93","author":"Tanvarasethee","year":"2013","journal-title":"Acta Derm Venereoll"},{"issue":"6","key":"10.1016\/j.anai.2022.06.014_bib0023","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/jdv.14890","article-title":"The measurement of drug-induced interferon \u03b3-releasing cells and lymphocyte proliferation in severe cutaneous adverse reactions","volume":"32","author":"Suthumchai","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.anai.2022.06.014_bib0024","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/bjd.14701","article-title":"In vitro test to confirm diagnosis of allopurinol-induced severe cutaneous adverse reactions","volume":"175","author":"Klaewsongkram","year":"2016","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.anai.2022.06.014_bib0025","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jdermsci.2017.03.007","article-title":"Novel interferon-\u03b3 enzyme-linked immunoSpot assay using activated cells for identifying hypersensitivity-inducing drug culprits","volume":"86","author":"Kato","year":"2017","journal-title":"J Dermatol Sci"},{"issue":"7","key":"10.1016\/j.anai.2022.06.014_bib0026","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1034\/j.1398-9995.2001.000115.x","article-title":"In vitro T-cell responses to \u03b2-lactam drugs in immediate and nonimmediate allergic reactions","volume":"56","author":"Luque","year":"2001","journal-title":"Allergy"},{"issue":"9","key":"10.1016\/j.anai.2022.06.014_bib0027","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1046\/j.1365-2222.2001.01164.x","article-title":"T cell involvement in cutaneous drug eruptions","volume":"31","author":"Hari","year":"2001","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"10.1016\/j.anai.2022.06.014_bib0028","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jdermsci.2011.12.002","article-title":"The predominant drug-specific T-cell population may switch from cytotoxic T cells to regulatory T cells during the course of anticonvulsant-induced hypersensitivity","volume":"65","author":"Hanafusa","year":"2012","journal-title":"J Dermatol Sci"},{"issue":"4","key":"10.1016\/j.anai.2022.06.014_bib0029","first-page":"293","article-title":"Multiple drug hypersensitivity-proof of multiple drug hypersensitivity by patch and lymphocyte transformation tests","volume":"15","author":"Gex-Collet","year":"2005","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2022.06.014_bib0030","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1046\/j.1365-2222.2000.00787.x","article-title":"Skin and laboratory tests in amoxicillin- and penicillin-induced morbilliform skin eruption","volume":"30","author":"Schnyder","year":"2000","journal-title":"Clin Exp Allergy"},{"issue":"11","key":"10.1016\/j.anai.2022.06.014_bib0031","doi-asserted-by":"crossref","first-page":"823","DOI":"10.20452\/pamw.3160","article-title":"Cytotoxic-based assays in delayed drug hypersensitivity reactions induced by antiepileptic drugs","volume":"125","author":"Porebski","year":"2015","journal-title":"Pol Arch Med Wewn"},{"issue":"1","key":"10.1016\/j.anai.2022.06.014_bib0032","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4049\/jimmunol.1100647","article-title":"Mass spectrometric characterization of circulating and functional antigens derived from piperacillin in patients with cystic fibrosis","volume":"187","author":"Whitaker","year":"2011","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.anai.2022.06.014_bib0033","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1046\/j.1365-2222.2000.00905.x","article-title":"Characterization of primary recall in vitro lymphocyte responses to Bacampicillin in allergic subjects","volume":"30","author":"Cederbrant","year":"2000","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"10.1016\/j.anai.2022.06.014_bib0034","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000358491","article-title":"Enhancement of drug-specific lymphocyte proliferation using CD25hi-depleted CD3+ effector cells","volume":"163","author":"Srinoulprasert","year":"2014","journal-title":"Int Arch Allergy Immunol"},{"issue":"2","key":"10.1016\/j.anai.2022.06.014_bib0035","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/bjd.14839","article-title":"Drug-specific CD4+ T-cell immune responses are responsible for antituberculosis drug-induced maculopapular exanthema and drug reaction with eosinophilia and systemic symptoms syndrome","volume":"176","author":"Ye","year":"2017","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.anai.2022.06.014_bib0036","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1023\/A:1018850805536","article-title":"Flow cytometric method to detect lymphocyte transformation in drug-allergic hepatic injury","volume":"43","author":"Ikeda","year":"1998","journal-title":"Dig Dis Sci"},{"issue":"12","key":"10.1016\/j.anai.2022.06.014_bib0037","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1111\/cea.12437","article-title":"Aminopenicillin-associated exanthem: lymphocyte transformation testing revisited","volume":"44","author":"Trautmann","year":"2014","journal-title":"Clin Exp Allergy"},{"issue":"12","key":"10.1016\/j.anai.2022.06.014_bib0038","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/j.1398-9995.1998.tb03835.x","article-title":"In vitro lymphocyte proliferation in the diagnosis of allergy to phenoxymethylpenicillin","volume":"53","author":"Cederbrant","year":"1998","journal-title":"Allergy"},{"issue":"7","key":"10.1016\/j.anai.2022.06.014_bib0039","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1346-8138.2011.01457.x","article-title":"HLA-A31 strongly associates with carbamazepine-induced adverse drug reactions but not with carbamazepine-induced lymphocyte proliferation in a Japanese population","volume":"39","author":"Niihara","year":"2012","journal-title":"J Dermatol"},{"issue":"4","key":"10.1016\/j.anai.2022.06.014_bib0040","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jaci.2006.07.013","article-title":"Potential involvement of dendritic cells in delayed-type hypersensitivity reactions to \u03b2-lactams","volume":"118","author":"Rodriguez-Pena","year":"2006","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2022.06.014_bib0041","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-2133.2008.08875.x","article-title":"Lymphocyte proliferation response in patients with delayed hypersensitivity reactions to heparins","volume":"160","author":"Lopez","year":"2009","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.anai.2022.06.014_bib0042","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jaci.2006.03.005","article-title":"Activation of T cells by carbamazepine and carbamazepine metabolites","volume":"118","author":"Wu","year":"2006","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.anai.2022.06.014_bib0043","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1046\/j.1365-2222.1999.00693.x","article-title":"T-cell reaction to local anaesthetics: relationship to angioedema and urticaria after subcutaneous application - patch testing and LTT in patients with adverse reaction to local anaesthetics","volume":"29","author":"Orasch","year":"1999","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"10.1016\/j.anai.2022.06.014_bib0044","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.iac.2014.04.009","article-title":"In vitro diagnosis of delayed-type drug hypersensitivity: mechanistic aspects and unmet needs","volume":"34","author":"Naisbitt","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"issue":"1","key":"10.1016\/j.anai.2022.06.014_bib0045","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/205873920601900112","article-title":"T cell assessment in allergic drug reactions during the acute phase according to the time of occurrence","volume":"19","author":"Torres","year":"2006","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"10","key":"10.1016\/j.anai.2022.06.014_bib0046","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/all.12260","article-title":"Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs","volume":"68","author":"Kowalski","year":"2013","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.anai.2022.06.014_bib0047","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2165\/00002018-200629020-00003","article-title":"Current understanding of contrast media reactions and implications for clinical management","volume":"29","author":"Meth","year":"2006","journal-title":"Drug Saf"},{"key":"10.1016\/j.anai.2022.06.014_bib0048","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.3389\/fimmu.2018.03027","article-title":"Mas-related G protein-coupled receptor-X2 (MRGPRX2) in drug hypersensitivity reactions","volume":"9","author":"Porebski","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.anai.2022.06.014_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111323","article-title":"MRGPRX2 mediates immediate-type pseudo-allergic reactions induced by iodine-containing iohexol","volume":"137","author":"Yuan","year":"2021","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.anai.2022.06.014_bib0050","doi-asserted-by":"crossref","first-page":"11628","DOI":"10.1038\/s41598-018-29965-8","article-title":"MRGPRX2-mediated mast cell response to drugs used in perioperative procedures and anaesthesia","volume":"8","author":"Navin\u00e9s-Ferrer","year":"2018","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.anai.2022.06.014_bib0051","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1084\/jem.20040341","article-title":"Rapid turnover of effector-memory CD4(+) T cells in healthy humans","volume":"200","author":"Macallan","year":"2004","journal-title":"J Exp Med"},{"issue":"12","key":"10.1016\/j.anai.2022.06.014_bib0052","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1111\/j.1398-9995.2007.01553.x","article-title":"Utility of the lymphocyte transformation test in the diagnosis of drug sensitivity: dependence on its timing and the type of drug eruption","volume":"62","author":"Kano","year":"2007","journal-title":"Allergy"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120622005336?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120622005336?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:30:03Z","timestamp":1761053403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120622005336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S1081120622005336"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2022.06.014","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lymphocyte transformation test for drug allergy detection","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2022.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}